17-63872154-C-G

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_020991.4(CSH2):​c.626G>C​(p.Arg209Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R209L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 29)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

CSH2
NM_020991.4 missense

Scores

8
6
4

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.01

Publications

1 publications found
Variant links:
Genes affected
CSH2 (HGNC:2441): (chorionic somatomammotropin hormone 2) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones and plays an important role in growth control. The gene is located at the growth hormone locus on chromosome 17 along with four other related genes in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. Although the five genes share a remarkably high degree of sequence identity, they are expressed selectively in different tissues. Alternative splicing generates additional isoforms of each of the five growth hormones. This particular family member is expressed mainly in the placenta and utilizes multiple transcription initiation sites. Expression of the identical mature proteins for chorionic somatomammotropin hormones 1 and 2 is upregulated during development, while the ratio of 1 to 2 increases by term. Structural and expression differences provide avenues for developmental regulation and tissue specificity. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.988

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020991.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSH2
NM_020991.4
MANE Select
c.626G>Cp.Arg209Pro
missense
Exon 5 of 5NP_066271.1P0DML3-1
CSH2
NM_022645.2
c.341G>Cp.Arg114Pro
missense
Exon 3 of 3NP_072171.1B1A4H9
CSH2
NM_022644.3
c.*375G>C
3_prime_UTR
Exon 4 of 4NP_072170.1A6NIT4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSH2
ENST00000392886.7
TSL:1 MANE Select
c.626G>Cp.Arg209Pro
missense
Exon 5 of 5ENSP00000376623.2P0DML3-1
CSH2
ENST00000613718.3
TSL:1
c.359G>Cp.Arg120Pro
missense
Exon 4 of 4ENSP00000478842.1A0A087WUG6
CSH2
ENST00000560142.5
TSL:5
c.455G>Cp.Arg152Pro
missense
Exon 5 of 5ENSP00000453452.1H0YM39

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251478
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461824
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111950
Other (OTH)
AF:
0.00
AC:
0
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
29

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Pathogenic
0.31
D
BayesDel_noAF
Pathogenic
0.29
CADD
Uncertain
26
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.90
D
Eigen
Benign
0.16
Eigen_PC
Benign
0.011
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.062
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.65
D
MutationAssessor
Pathogenic
3.7
H
PhyloP100
4.0
PrimateAI
Benign
0.47
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Pathogenic
0.74
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Vest4
0.92
MutPred
0.93
Gain of glycosylation at S214 (P = 0.076)
MVP
0.84
ClinPred
0.92
D
GERP RS
3.0
Varity_R
0.68
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375686495; hg19: chr17-61949514; API